Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Receptors, IgG/immunology"'
Systems serology detects functionally distinct coronavirus antibody features in children and elderly
Autor:
Allen C. Cheng, Francesca L Mordant, Katherine Kedzierska, Keith J. Chappell, Daniel Watterson, Brendon Y. Chua, Hannah G. Kelly, Suzanne K. Shoffner, Jane Crowe, Carolien E. van de Sandt, Melissa M. Lemke, Naphak Modhiran, Bruce D. Wines, Fatima Amanat, Thi H. O. Nguyen, Adam K. Wheatley, Marios Koutsakos, Wen Shi Lee, Hyon-Xhi Tan, Luca Hensen, Kelly B. Arnold, David C. Jackson, Paul R. Young, Amy W. Chung, Paul V. Licciardi, Katie L. Flanagan, Shidan Tosif, Samantha K Davis, Louise C. Rowntree, Chinn Yi Wong, Jennifer A Juno, Stephen J. Kent, Nigel W Crawford, P. Mark Hogarth, Philip Sutton, Melanie R Neeland, Robyn Esterbauer, Kevin J. Selva, Florian Krammer, Denise L. Doolan, Christina Lee
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Nature Communications, 12(1):2037
Nature Communications
Nature communications, 12(1). Nature Publishing Group
Nature Communications, 12(1):2037
Nature Communications
Nature communications, 12(1). Nature Publishing Group
The hallmarks of COVID-19 are higher pathogenicity and mortality in the elderly compared to children. Examining baseline SARS-CoV-2 cross-reactive immunological responses, induced by circulating human coronaviruses (hCoVs), is needed to understand su
Autor:
Bianca Balbino, Julien Stackowicz, Kari C. Nadeau, Pauline Herviou, Ophélie Godon, Sébastien Brûlé, Delphine Sterlin, Andrew J. Murphy, Vera Voronina, Bruno Iannascoli, Odile Richard-Le Goff, Gaël A. Millot, Macdonald Lynn, Laurent L. Reber, Harris Faith, Pierre Bruhns
Publikováno v:
Journal of Clinical Investigation
Journal of Clinical Investigation, 2019, ⟨10.1172/JCI129697⟩
Journal of Clinical Investigation, American Society for Clinical Investigation, 2019, ⟨10.1172/JCI129697⟩
J Clin Invest
Journal of Clinical Investigation, 2019, ⟨10.1172/JCI129697⟩
Journal of Clinical Investigation, American Society for Clinical Investigation, 2019, ⟨10.1172/JCI129697⟩
J Clin Invest
International audience; Omalizumab is an anti-IgE monoclonal antibody (mAb) approved for the treatment of severe asthma and chronic spontaneous urticaria. Use of Omalizumab is associated with reported side effects, ranging from local skin inflammatio
Publikováno v:
Springer Seminars in Immunopathology, Vol. 23, No 4 (2001) pp. 433-445
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::616ceb297fa77406322e651939317f2e
http://doc.rero.ch/record/315456/files/281_2009_Article_10230433281.pdf
http://doc.rero.ch/record/315456/files/281_2009_Article_10230433281.pdf
Autor:
Hans Jürgen Hoffmann, Pernille Munk Frandsen, Ronald Dahl, Gitte Lund, Inge Kortekaas Krohn, Peter Oluf Schiøtz
Publikováno v:
Krohn, I K, Lund, G, Frandsen, P M, Schiøtz, P O, Dahl, R & Hoffmann, H J 2013, ' Mast cell FcϵRI density and function dissociate from dependence on soluble IgE concentration at very low and very high IgE concentrations ', Journal of Asthma, vol. 50, no. 2, pp. 117-21 . https://doi.org/10.3109/02770903.2012.752504
OBJECTIVE: The contribution of affinity, clonality, and concentration of individual IgE species to effector cell response has recently been characterized in a model with recombinant human IgE on passively sensitized basophils. This study extends the
Autor:
Takashi Saito, Shozo Izui, J. Sjef Verbeek, Mark Walport, Liliane Fossati-Jimack, Shuichi Kikuchi, Michael C. Carroll, Marina Botto, Samareh Azeredo da Silveira, Thomas Moll
Publikováno v:
ResearcherID
Journal of Experimental Medicine, Vol. 195, No 6 (2002) pp. 665-672
The Journal of Experimental Medicine
Journal of Experimental Medicine, Vol. 195, No 6 (2002) pp. 665-672
The Journal of Experimental Medicine
By generating four IgG isotype-switch variants of the high affinity 34–3C anti-erythrocyte autoantibody, and comparing them to the IgG variants of the low affinity 4C8 anti-erythrocyte autoantibody that we have previously studied, we evaluated in t
Autor:
Bruno Daubeuf, Walter Reith, Yann Dean, Romain Roger Ballet, Laura Cons, Eric Hatterer, Sophie Glatt, Marie Kosco-Vilbois, Fabien Dépis
Publikováno v:
mAbs, Vol. 5, No 4 (2013) pp. 555-64
Fc-modified anti-human CD3ε monoclonal antibodies (mAbs) are in clinical development for the treatment of autoimmune diseases. These next generation mAbs have completed clinical trials in patients with type-1 diabetes and inflammatory bowel disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a644fbe67bebfa836b2788eb731f7343
https://europepmc.org/articles/PMC3906309/
https://europepmc.org/articles/PMC3906309/